217 related articles for article (PubMed ID: 27864349)
1. Substantial Equivalence Standards in Tobacco Governance: Statutory Clarity and Regulatory Precedent for the FSPTCA.
Carpenter D; Connolly GN; Lempert LK
J Health Polit Policy Law; 2017 Aug; 42(4):607-644. PubMed ID: 27864349
[TBL] [Abstract][Full Text] [Related]
2. Tobacco products, exemptions from substantial equivalence requirements. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2011 Jul; 76(128):38961-75. PubMed ID: 21735763
[TBL] [Abstract][Full Text] [Related]
3. FDA's misplaced priorities: premarket review under the Family Smoking Prevention and Tobacco Control Act.
Jenson D; Lester J; Berman ML
Tob Control; 2016 May; 25(3):246-53. PubMed ID: 27068243
[TBL] [Abstract][Full Text] [Related]
4. No sisyphean task: how the FDA can regulate electronic cigarettes.
Paradise J
Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
[TBL] [Abstract][Full Text] [Related]
5. Has the tobacco industry evaded the FDA's ban on 'Light' cigarette descriptors?
Connolly GN; Alpert HR
Tob Control; 2014 Mar; 23(2):140-5. PubMed ID: 23485704
[TBL] [Abstract][Full Text] [Related]
6. Research gaps related to tobacco product marketing and sales in the Family Smoking Prevention and Tobacco Control Act.
Ribisl KM
Nicotine Tob Res; 2012 Jan; 14(1):43-53. PubMed ID: 21690316
[TBL] [Abstract][Full Text] [Related]
7. Tobacco regulatory science: research to inform regulatory action at the Food and Drug Administration's Center for Tobacco Products.
Ashley DL; Backinger CL; van Bemmel DM; Neveleff DJ
Nicotine Tob Res; 2014 Aug; 16(8):1045-9. PubMed ID: 24638850
[TBL] [Abstract][Full Text] [Related]
8. Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.
Tan CE; Kyriss T; Glantz SA
PLoS Med; 2013; 10(5):e1001450. PubMed ID: 23723740
[TBL] [Abstract][Full Text] [Related]
9. Clove cigar sales following the US flavoured cigarette ban.
Delnevo CD; Hrywna M
Tob Control; 2015 Dec; 24(e4):e246-50. PubMed ID: 24652459
[TBL] [Abstract][Full Text] [Related]
10. Public Knowledge and Credibility Perceptions of the FDA as a Tobacco Regulator.
Schmidt AM; Jarman KL; Ranney LM; Queen TL; Noar SM; Ruel L; Agans R; Hannan A; Goldstein AO
Nicotine Tob Res; 2018 Sep; 20(11):1310-1316. PubMed ID: 29059369
[TBL] [Abstract][Full Text] [Related]
11. Information to Improve Public Perceptions of the Food and Drug Administration (FDA's) Tobacco Regulatory Role.
Osman A; Kowitt SD; Sheeran P; Jarman KL; Ranney LM; Goldstein AO
Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29661991
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation.
Chaloupka FJ; Warner KE; Acemoğlu D; Gruber J; Laux F; Max W; Newhouse J; Schelling T; Sindelar J
Tob Control; 2015 Mar; 24(2):112-9. PubMed ID: 25550419
[TBL] [Abstract][Full Text] [Related]
13. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2016 May; 81(90):28973-9106. PubMed ID: 27192730
[TBL] [Abstract][Full Text] [Related]
14. FDA regulation of tobacco: blessing or curse for FDA professionals?
O'Reilly JT
Food Drug Law J; 2009; 64(3):459-72. PubMed ID: 19999639
[TBL] [Abstract][Full Text] [Related]
15. Federal approaches to the regulation of noncigarette tobacco products.
Freiberg MJ
Am J Prev Med; 2012 Nov; 43(5 Suppl 3):S249-54. PubMed ID: 23079224
[TBL] [Abstract][Full Text] [Related]
16. A critical assessment of the scientific basis, and implementation, of regulations for the safety assessment and marketing of innovative tobacco-related products.
Combes RD; Balls M
Altern Lab Anim; 2015 Sep; 43(4):251-90. PubMed ID: 26375889
[TBL] [Abstract][Full Text] [Related]
17. Tobacco under the FDA: a summary of the Family Smoking Prevention and Tobacco Control Act.
Lundeen RE
Health Care Law Mon; 2009 Sep; 2009(9):2-9. PubMed ID: 19771935
[No Abstract] [Full Text] [Related]
18. Smokers' reactions to FDA regulation of tobacco products: findings from the 2009 ITC United States survey.
Fix BV; O'Connor RJ; Fong GT; Borland R; Cummings KM; Hyland A
BMC Public Health; 2011 Dec; 11():941. PubMed ID: 22177316
[TBL] [Abstract][Full Text] [Related]
19. Vuse Solo e-cigarettes do not provide net benefits to public health: a scientific analysis of FDA's marketing authorisation.
Glantz S; Lempert LK
Tob Control; 2024 Mar; 33(e1):e108-e115. PubMed ID: 36764683
[TBL] [Abstract][Full Text] [Related]
20. Research priorities and infrastructure needs of the Family Smoking Prevention and Tobacco Control Act: science to inform FDA policy.
Leischow SJ; Zeller M; Backinger CL
Nicotine Tob Res; 2012 Jan; 14(1):1-6. PubMed ID: 22184581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
